Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 68 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 9200265

    Anti-cocaine compositions and treatment

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted

  2. US 9193709

    1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases

    Takeda Pharmaceutical Company Limited · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted

  3. US 9192628

    Treatment method for relapsing-remitting multiple sclerosis

    REGENEX LLC · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted

  4. US 9181577

    Treatment of chronic pelvic pain syndrome

    Northwestern University · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  5. US 9175062

    Human soluble receptor for advanced glycation end products (sRAGE), methods of preparing human sRAGE, and treatment methods using sRAGE

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  6. US 9175058

    Soluble immune response suppressor polypeptides and treatment of multiple sclerosis and other autoimmune diseases

    The Board of Regents of the University of Texas System · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  7. US 9173896

    RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions

    Arrowhead Research Corporation · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  8. US 9169313

    Method of treatment of cancers characterized by ligand-dependent activating mutations in FGFR2 with FGFR1 ECD proteins

    Five Prime Therapeutics, Inc. · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  9. US 9161735

    Systems, compositions, and methods for local imaging and treatment of pain

    The Regents of the University of California · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

  10. US 9163258

    Method for the treatment of obesity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

  11. US 9161936

    Laquinimod for treatment of GABA mediated disorders

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

  12. US 9162968

    Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis

    Northwestern University · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

  13. US 9156853

    AKT inhibitor compounds for treatment of cancer

    ALMAC DISCOVERY LIMITED · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted

  14. US 9157121

    Method of treatment based on polymorphisms of the KCNQ1 gene

    VANDA PHARMACEUTICALS INC. · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted

  15. US 9149483

    Methods for treatment of diseases

    Galera Labs, LLC · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  16. US 9149489

    Inhibitors of glycolysis useful in the treatment of brain tumors

    The Board of Regents of the University of Texas System · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  17. US 9150862

    siRNA targeting VEGFA and methods for treatment in vivo

    Arrowhead Research Corporation · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  18. US 9149445

    Inhibition of glycerol-3-phosphate acyltransferase (GPAT) and associated enzymes for treatment of viral infections

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  19. US 9150926

    Diagnosis and treatment of adrenocortical tumors using human microRNA-483

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  20. US 9149437

    Method for treatment of solid pharmaceutical preparation prior to printing and solid pharmaceutical preparation subjected to treatment prior to printing

    Takeda Pharmaceutical Company Limited · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  21. US 9149537

    Compositions and methods for the treatment of traumatic brain injury

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  22. MX 2015008685

    TREATMENT OF PSORIATIC ARTHRITIS USING APREMILAST.

    CELGENE CORP [US] · Granted Oct 5, 2015 · Expires Sep 30, 2035

    granted

  23. US 9138479

    Formulations for the treatment of diabetes

    XERIS PHARMACEUTICALS, INC. · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  24. US 9139834

    RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesis

    Arrowhead Research Corporation · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.